1. Multicenter retrospective study to evaluate the impact of trabectedin plus pegylated liposomal doxorubicin on the subsequent treatment in women with recurrent, platinum-sensitive ovarian cancer. Issue 6 (July 2019) Authors: Romero, Ignacio; Mallol, Pedro; Santaballa, Ana; Del Campo, Jose M.; Mori, Marta; González-Santiago, Santiago; Casado, Antonio; Vicente, David; Ortega, Eugenia; Herrero, Ana; Guerra, Eva; Barretina-Ginesta, Pilar; Rubio, María J.; Martínez, Alejandro; Bover, Isabel; Vidal, Laura; Arcusa, Ángels; ... Journal: Anti-cancer drugs Issue: Volume 30:Issue 6(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SNPs and taxane toxicity in breast cancer patients. (November 2014) Authors: Bosó, Virginia; Herrero, María José; Santaballa, Ana; Palomar, Laura; Megias, Juan E; de la Cueva, Helena; Rojas, Luis; Marqués, María Remedios; Poveda, José Luis; Montalar, Joaquin; Aliño, Salvador F Journal: Pharmacogenomics Issue: Volume 15:Number 15(2014) Page Start: 1845 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer. Issue 4 (April 2022) Authors: Harter, Philipp; Sehouli, Jalid; Vergote, Ignace; Ferron, Gwenael; Reuss, Alexander; Meier, Werner; Greggi, Stefano; Mosgard, Berit J.; Selle, Frederic; Guyon, Frederic; Pomel, Christophe; Lécuru, Fabrice; Zang, Rongyu; Avall-Lundqvist, Elisabeth; Kim, Jae‐Weon; Ponce, Jordi; Raspagliesi, Frances... Journal: Obstetrical & gynecological survey Issue: Volume 77:Issue 4(2022) Page Start: 216 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study. (June 2022) Authors: Martín, Miguel; Zielinski, Christoph; Ruiz-Borrego, Manuel; Carrasco, Eva; Ciruelos, Eva M.; Muñoz, Montserrat; Bermejo, Begoña; Margelí, Mireia; Csöszi, Tibor; Antón, Antonio; Turner, Nicholas; Casas, María I.; Morales, Serafín; Alba, Emilio; Calvo, Lourdes; de la Haba-Rodríguez, Juan; Ramos, Ma... Journal: European journal of cancer Issue: Volume 168(2022) Page Start: 12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 2022-RA-466-ESGO Long-term responders (LTR) to rucaparib in recurrent ovarian cancer: a sub-group analysis from the rucaparib access (RAP) program in Spain by GEICO. (20th October 2022) Authors: Yubero, Alfonso; Barquín, Aranzazu; Gaba, Lydia; Pajares, Bella; Reche, Piedad; Salvador, Carmen; Alarcón, Jesús; Manso, Luis; Marquez, Raúl; Fuentes, Jose; Madani, Julia; Costenla, Manuel; Gutierrez-Toribio, Maria; Estevez-García, Purificacion; Santaballa, Ana; Sanchez-Lorenzo, Luisa; Calzas, Ju... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A238 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions. MHT Eligibility Criteria Group. (December 2022) Authors: Mendoza, Nicolás; Ramírez, Isabel; de la Viuda, Esther; Coronado, Pluvio; Baquedano, Laura; Llaneza, Plácido; Nieto, Verónica; Otero, Borja; Sánchez-Méndez, Sonia; de Frutos, Visitación Álvarez; Andraca, Leire; Barriga, Patricio; Benítez, Zully; Bombas, Teresa; Cancelo, Mª. Jesús; Cano, Antonio; ... Journal: Maturitas Issue: Volume 166(2022) Page Start: 65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Lurbinectedin in patients with pretreated neuroendocrine tumours: Results from a phase II basket study. (September 2022) Authors: Longo-Muñoz, Federico; Castellano, Daniel; Alexandre, Jerome; Chawla, Sant P.; Fernández, Cristian; Kahatt, Carmen; Alfaro, Vicente; Siguero, Mariano; Zeaiter, Ali; Moreno, Victor; Sanz-García, Enrique; Awada, Ahmad; Santaballa, Ana; Subbiah, Vivek Journal: European journal of cancer Issue: Volume 172(2022) Page Start: 340 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. GEICO1601-ROLANDO: a multicentric single arm Phase II clinical trial to evaluate the combination of olaparib and pegylated liposomal doxorubicin for platinum-resistant ovarian cancer. (10th January 2019) Authors: Perez-Fidalgo, J Alejandro; Iglesias, Maria; Bohn, Uriel; Calvo, Elisa; Garcia, Yolanda; Guerra, Eva; Manso, Luis; Santaballa, Ana; Gonzalez-Martin, Antonio Journal: Future science OA Issue: Volume 5:Number 2(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Feasibility and Safety of a Modified Outpatient Regimen With Intravenous/Intraperitoneal Chemotherapy for Optimally Debulked Stage III Ovarian Cancer. Issue 2 (1st February 2015) Authors: Bruixola, Gema; Domingo, Santiago; Díaz, Roberto; Caballero, Javier; Palomar, Laura; De La Cueva, Helena; Santaballa, Ana Journal: International journal of gynecological cancer Issue: Volume 25:Issue 2(2015:Feb.) Page Start: 214 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Immunosuppressive profiles in liquid biopsy at diagnosis predict response to neoadjuvant chemotherapy in triple-negative breast cancer. (November 2020) Authors: Salvador-Coloma, Carmen; Santaballa, Ana; Sanmartín, Elena; Calvo, David; García, Ana; Hervás, David; Cordón, Lourdes; Quintas, Guillermo; Ripoll, Francisco; Panadero, Joaquín; Font de Mora, Jaime Journal: European journal of cancer Issue: Volume 139(2020) Page Start: 119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗